SRTA Stock Analysis: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$6.21
-0.05 (-0.80%)
▼
5d:
-0.8%
30d:
+26.73%
90d:
+26.99%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $6.21, which is considered extended relative to its 30-day fair value range of $5.06 to $6.06. From a valuation perspective, the stock is trading at a discount (Forward PE: -310.5) compared to its historical average (61.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTA is in a uptrend. Immediate support is located at $5.18, while resistance sits at $6.50.
Market Sentiment: SRTA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.12 (+46.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRTA is in a uptrend. Immediate support is located at $5.18, while resistance sits at $6.50.
Market Sentiment: SRTA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $9.12 (+46.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.06 -
$6.06
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.9% below Wall St target ($9.12)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$5.06 -
$6.06
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.68
(10.9%)
Support & Resistance Levels
Support Level
$5.19
Resistance Level
$6.50
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-310.50
Wall Street Target
$9.13
(+46.9%)
Revenue Growth (YoY)
87.4%
Profit Margin
20.6%
PE vs Historical
-310.5 vs 61.6
CHEAP
Share & Embed Analysis
Last updated: June 03, 2026 7:36 PM ET
Data refreshes hourly during market hours. Next update: 8:36 PM
Data refreshes hourly during market hours. Next update: 8:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$245 | 50 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$511 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 67 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$142 | 56 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 55 HOLD |